Mid-Year Report

INFECTIOUS DISEASES SOCIETY OF AMERICA for INFECTIOUS DISEASES SOCIETY OF AMERICA

Firm
Client
Income
—
Expenses
$180,864

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Funding support for the Department of Health and Human Services, Centers for Disease Control and Prevention, National Institutes of Health, Health Resources and Services Administration, Food and Drug Administration and global programs for various infectious diseases-related issues.

LobbyistCovered position, as disclosed
ROBERT J GUIDOS DIRECTOR, PUBLIC POLICY & GOVERNMENT RELATION
JULIE HANTMAN SENIOR PROGRAM OFFICER FOR PUBLIC HEALTH
CHRISTINE LUBINSKI EXECUTIVE DIRECTOR, HIV MEDICINE ASSOCIATION
JENNIFER MRAZ —
BETH RADA PROGRAM OFFICER FOR SCIENCE & RESEARCH
JASON SCULL PROGRAM OFFICER FOR CLINICAL AFFAIRS
ANDREA WEDDLE ASSOCIATE DIRECTOR, HIV MEDICINE ASSOCIATION

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); SENATE

Medical/Disease Research/Clinical Labs MED

Medical liability; Antimicrobial resistance research; infectious diseases product research and development

LobbyistCovered position, as disclosed
ROBERT J GUIDOS DIRECTOR, PUBLIC POLICY & GOVERNMENT RELATION
JULIE HANTMAN SENIOR PROGRAM OFFICER FOR PUBLIC HEALTH
CHRISTINE LUBINSKI EXECUTIVE DIRECTOR, HIV MEDICINE ASSOCIATION
JENNIFER MRAZ —
BETH RADA PROGRAM OFFICER FOR SCIENCE & RESEARCH
JASON SCULL PROGRAM OFFICER FOR CLINICAL AFFAIRS
ANDREA WEDDLE ASSOCIATE DIRECTOR, HIV MEDICINE ASSOCIATION

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA)

Health Issues HCR

Infectious diseases; drug and vaccine research and development; antimicrobial resistance; immunizations; pandemic influenza, public health security and bioterrorism; global infectious diseases; biomedical research, Ryan White Reauthorization; Lyme disease and other infectious diseases issues.

LobbyistCovered position, as disclosed
ROBERT J GUIDOS DIRECTOR, PUBLIC POLICY & GOVERNMENT RELATION
JULIE HANTMAN SENIOR PROGRAM OFFICER FOR PUBLIC HEALTH
CHRISTINE LUBINSKI EXECUTIVE DIRECTOR, HIV MEDICINE ASSOCIATION
JENNIFER MRAZ —
BETH RADA PROGRAM OFFICER FOR SCIENCE & RESEARCH
JASON SCULL PROGRAM OFFICER FOR CLINICAL AFFAIRS
ANDREA WEDDLE ASSOCIATE DIRECTOR, HIV MEDICINE ASSOCIATION

Contacted: Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); SENATE; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Competitive Acquisition Program Medicare Part D vaccine coverage and formulary issues Reimbursement for outpatient and home-based infusion therapy Physician payment and coding Medicaid and Medicare Reform, including Medicare Prescription Drug Coverage Average Sales Price

LobbyistCovered position, as disclosed
ROBERT J GUIDOS DIRECTOR, PUBLIC POLICY & GOVERNMENT RELATION
JULIE HANTMAN SENIOR PROGRAM OFFICER FOR PUBLIC HEALTH
CHRISTINE LUBINSKI EXECUTIVE DIRECTOR, HIV MEDICINE ASSOCIATION
JENNIFER MRAZ —
BETH RADA PROGRAM OFFICER FOR SCIENCE & RESEARCH
JASON SCULL PROGRAM OFFICER FOR CLINICAL AFFAIRS
ANDREA WEDDLE ASSOCIATE DIRECTOR, HIV MEDICINE ASSOCIATION

Contacted: Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); SENATE; Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.